NIH Women's Health Research Roundtable: The Gut Microbiome and Women’s Health
Date and Time
– July 30, 2026, 4:00 PM EDTThe Women’s Health Research Roundtable presents a lecture series focused on a range of issues impacting women’s health. This virtual webinar will explore the gut microbiome and women's health.
Negar Fani, PhD, ABPP
Associate Professor of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Talk Title: Social Stressors and the Gut-brain Axis: Mechanisms of Vulnerability and Intervention for Psychiatric Disorders in Women
Saori Furuta, PhD
Associate Professor, Cancer Biology
Case Western Reserve University
Talk Title: To Be Provided
Click here to register for this event.
WHO SHOULD ATTEND
This activity is intended for the biomedical research community and healthcare providers. A secondary audience is the general public, to enhance awareness of NIH-supported findings in women’s health research.
GLOBAL OBJECTIVES
After attending this activity, the learner will demonstrate the ability to:
- Implement a structured, collaborative, and iterative approach to disseminating medical education across Johns Hopkins Medicine and its affiliates.
- Identify and evaluate systems-based and practice-based processes to improve patient safety and quality of care through data driven analysis and continuous improvement strategies.
- Evaluate recent research, new techniques and clinical guidelines for their design quality, validity, and relevance to patient care, and implement those that improve treatment effectiveness.
- Promote patient-centered, team-based communication strategies among healthcare stakeholders to optimize care coordination and decision-making.
- Analyze and compare patient outcomes from historical and current cases to refine clinical decision-making and develop more effective treatment strategies.
ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This regularly scheduled series has been approved for a 52-week cycle beginning January 29, 2026.
It is the policy of the Johns Hopkins University School of Medicine that the presenter and provider globally disclose conflicts of interest and any discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.